Your browser doesn't support javascript.
loading
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
White, Harvey D; Steg, Ph Gabriel; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Edelberg, Jay M; Erglis, Andrejs; Goodman, Shaun G; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Lopes, Renato D; Mahaffey, Kenneth W; Moryusef, Angele; Pordy, Robert; Roe, Matthew T; Sritara, Piyamitr; Tricoci, Pierluigi; Zeiher, Andreas M; Schwartz, Gregory G.
Afiliação
  • White HD; Green Lane Cardiovascular Services, Auckland City Hospital, 5 Park Road, Grafton, Auckland, New Zealand.
  • Steg PG; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Université Paris-Diderot, Sorbonne Paris-Cité, INSERM U-1148, 46 rue Henri Huchard, Paris, France.
  • Szarek M; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, Sydney Street, London, UK.
  • Bhatt DL; Department of Epidemiology and Biostatistics, SUNY Downstate Medical Center School of Public Health, 450 Clarkson Avenue, Brooklyn, USA.
  • Bittner VA; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, 75 Francis Street, Boston, USA.
  • Diaz R; Division of Cardiovascular Disease, University of Alabama at Birmingham, 701 19th Street South - LHRB 310, Birmingham, USA.
  • Edelberg JM; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Paraguay 160, Rosario, Santa Fe, Argentina.
  • Erglis A; Sanofi, 55 Corporate Drive, Bridgewater, USA.
  • Goodman SG; Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, University of Latvia, Pilsonu Street 13, Riga, Latvia.
  • Hanotin C; Canadian VIGOUR Centre, 2-132 Li Ka Shing Centre for Health Research Innovation University of Alberta, Edmonton, Alberta, Canada.
  • Harrington RA; St. Michael's Hospital, 30 Bond Street, University of Toronto, Toronto, ON, Canada.
  • Jukema JW; Sanofi, 54-56 Rue la Boétie, Paris, France.
  • Lopes RD; Stanford Center for Clinical Research, Department of Medicine, 300 Pasteur Drive, S-102, Stanford, CA, USA.
  • Mahaffey KW; Department of Cardiology, Leiden University Medical Center, RC Leiden, The Netherlands.
  • Moryusef A; Duke Clinical Research Institute, 200 Morris Street, Durham, NC, USA.
  • Pordy R; Department of Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Grant S-102, Stanford, CA, USA.
  • Roe MT; Sanofi, 55 Corporate Drive, Bridgewater, USA.
  • Sritara P; Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, USA.
  • Tricoci P; Duke Clinical Research Institute, 200 Morris Street, Durham, NC, USA.
  • Zeiher AM; Department of Medicine, Faculty of Medicine, Ramathibodi Hospital/Mahidol University, Rama VI Road, Thailand.
  • Schwartz GG; CSL Behring, 1100 N Miami Blvd Ste 613, Durham, NC, USA.
Eur Heart J ; 40(33): 2801-2809, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31121022
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Nova Zelândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Nova Zelândia